세계의 가상 종양학 시장 : 컴포넌트별, 암 유형별, 용도별, 최종사용자별, 지역별
Virtual Oncology Market, By Component, By Cancer Type, By Application, By End User, By Geography
상품코드
:
1741528
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
가상 종양학 시장은 2025년 47억 3,000만 달러, 2032년에는 149억 8,000만 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR)은 17.9%를 나타낼 전망입니다.
| 보고서 범위 |
보고서 상세 |
| 기준 연도 |
2024 |
2025년 시장 규모 |
47억 3,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간(2025-2032년) CAGR |
17.90% |
2032년 가치 예측 |
149억 8,000만 달러 |
가상 종양학은 원격 암 치료 및 지원 서비스를 제공하기 위해 기술을 활용하는 헬스케어 분야의 신흥 분야입니다. 원격 의료, 가상 진료, 원격 모니터링, 개인별 맞춤 치료 계획 등 다양한 디지털 솔루션이 포함됩니다. 가상 종양학의 목적은 환자 결과를 개선하고, 치료 접근성을 높이며, 전반적인 환자 경험을 개선하는 것입니다.
기술의 발전과 전 세계 암 유병률 증가로 인해 가상 종양학은 최근 몇 년 동안 큰 지지를 받고 있습니다. 이 접근법은 환자의 이동 시간 및 비용 절감, 전문가 의견에 대한 접근성 향상, 환자의 건강 상태를 원격으로 모니터링할 수 있는 능력 등 여러 가지 이점이 있습니다. 또한, 환자 개개인의 필요와 선호도에 따라 보다 맞춤 치료 옵션을 제공할 수 있습니다.
시장 역학:
가상 종양학 시장은 암 유병률 증가, 원격 의료 서비스에 대한 수요 증가, 기술 발전 등의 요인으로 인해 향후 몇 년 동안 큰 폭의 성장이 예상됩니다. 또한, 코로나19 사태로 인해 병원 및 진료소가 대면 진료를 줄이고 감염 위험을 최소화하는 데 집중하면서 가상 종양학 솔루션의 채택이 더욱 가속화되고 있습니다.
그러나 시장 성장을 저해할 수 있는 문제도 있습니다. 데이터 보안, 환자 프라이버시 문제, 규제 장벽 등이 시장 관계자들에게 큰 걸림돌로 작용하고 있습니다. 또한, 가상 기술에 능통한 숙련된 의료진의 부족과 시스템 도입에 따른 높은 비용도 시장 확대를 제한할 수 있습니다.
그럼에도 불구하고, 가상 종양학 시장은 기존 및 신규 시장 참여자 모두에게 몇 가지 기회를 제공합니다. 가상 종양학 분야에서 인공지능(AI)과 머신러닝 알고리즘의 채택이 증가함에 따라 진단, 치료 계획, 환자 모니터링을 개선하는 데 도움이 될 수 있습니다. 또한, 혁신적인 솔루션을 개발하고 환자 참여를 강화하기 위한 기술 기업과 의료 서비스 제공업체의 협업은 시장 발전을 촉진할 것으로 예측됩니다.
본 조사의 주요 특징
- 본 보고서는 2024년을 기준 연도로 하여 2025-2032년까지의 예측 기간 동안 시장 규모(단위: 10억 달러)와 연평균 성장률(CAGR)을 포함한 세계 가상 종양학 시장을 상세하게 분석하였습니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰을 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 가상 종양학 시장의 주요 기업을 프로파일링합니다.
- 이 조사의 주요 대상 기업은 Flatiron Health,McKesson Corporation,Cerner Corporation,Koninklijke Philips N.V.,Siemens Healthcare Private Limited,Crisp,Varian Medical Systems, Inc.,Elekta AB,Accuray Incorporated,C-TAC Health,Oscar Health,NXGN Management, LLC,Epic Systems Corporation,Optum, Inc. Orchestrate.AI, CureMatch, Inc. 등입니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 가상 종양학 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 가상 종양학 시장 분석에 사용된 다양한 전략 매트릭스로부터 이익을 얻을 수 있으며, 의사결정 과정에 도움을 받을 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 발매 및 승인
- PEST 분석
- PORTER 분석
- 인수합병(M&A) 시나리오
제4장 가상 종양학 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측 분석
- 경제에 대한 영향
제5장 가상 종양학 시장, 컴포넌트별, 2020년-2032년
제6장 가상 종양학 시장, 암 유형별, 2020년-2032년
- 폐암
- 유방암
- 대장암
- 전립선암
- 간암
- 방광암
- 기타(췌장, 난소 등)
제7장 가상 종양학 시장, 용도별, 2020년-2032년
- 정밀의료
- 환자 케어 관리
- 연구개발
- 임상시험
- 진단 및 치료 의사결정
- 데이터 관리
- 기타(청구 관리, 규제 준수 등)
제8장 가상 종양학 시장, 최종사용자별, 2020년-2032년
- 병원 및 진단영상센터
- 학술기관 및 연구센터
- 제약 기업 및 바이오테크놀러지 기업
- 계약연구기관(CRO)
- 기타(검사기관, 약국 등)
제9장 가상 종양학 시장, 지역별, 2020년-2032년
- 북미
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 라틴아메리카
- 중동
- 아프리카
제10장 경쟁 구도
- Flatiron Health
- McKesson Corporation
- Cerner Corporation
- Koninklijke Philips N.V.
- Siemens Healthcare Private Limited
- Crisp
- Varian Medical Systems, Inc.
- Elekta AB
- Accuray Incorporated
- C-TAC Health
- Oscar Health
- NXGN Management, LLC
- Epic Systems Corporation
- Optum, Inc
- AI
- CureMatch, Inc.
- Oncora Medical
제11장 섹션
LSH
영문 목차
Virtual Oncology Market is estimated to be valued at USD 4.73 Bn in 2025 and is expected to reach USD 14.98 Bn by 2032, growing at a compound annual growth rate (CAGR) of 17.9% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 4.73 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
17.90% |
2032 Value Projection: |
USD 14.98 Bn |
Virtual oncology is an emerging field in healthcare that utilizes technology to provide remote cancer care and support services. It encompasses various digital solutions such as telemedicine, virtual consultations, remote monitoring, and personalized treatment plans. The aim of virtual oncology is to improve patient outcomes, increase access to care, and enhance the overall patient experience.
With advancements in technology and the increasing prevalence of cancer worldwide, virtual oncology has gained significant traction in recent years. This approach offers several benefits, including reduced travel time and costs for patients, improved access to expert opinions, and the ability to monitor patients' health remotely. It also allows for more personalized treatment options based on individual patient needs and preferences.
Market Dynamics:
The virtual oncology market is expected to witness substantial growth in the coming years, primarily driven by factors such as the increasing prevalence of cancer, the growing need for remote healthcare services, and advancements in technology. Additionally, the COVID-19 pandemic has further accelerated the adoption of virtual oncology solutions as hospitals and clinics focus on reducing in-person visits and minimizing the risk of infections.
However, there are certain challenges that may restrain market growth. Concerns regarding data security and patient privacy, along with regulatory barriers, pose significant hurdles for market players. Moreover, the lack of skilled healthcare professionals proficient in virtual technologies and the high costs associated with implementing such systems may limit the market's expansion.
Nevertheless, the virtual oncology market presents several opportunities for both existing and new market players. The increasing adoption of artificial intelligence (AI) and machine learning algorithms in virtual oncology can help improve diagnosis, treatment planning, and patient monitoring. Additionally, collaborations between technology companies and healthcare providers to develop innovative solutions and enhance patient engagement are expected to drive market growth.
Key Features of the Study:
- This report provides in-depth analysis of the global virtual oncology market, including market size (in US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global virtual oncology market based on parameters such as company highlights, product portfolio, key highlights, financial performance, and strategies.
- Key companies covered in this study include Flatiron Health, McKesson Corporation, Cerner Corporation, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Crisp, Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, C-TAC Health, Oscar Health, NXGN Management, LLC, Epic Systems Corporation, Optum, Inc, Orchestrate.AI, CureMatch, Inc., Oncora Medical
- Insights from this report would enable marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics.
- The global virtual oncology market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders will benefit from the various strategy matrices used in analyzing the global virtual oncology market, which will aid in decision-making processes.
Virtual Oncology Market Segmentation:
- Virtual Oncology Market, By Component
- Software
- Service
- Hardware
- Virtual Oncology Market, By Cancer Type
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Liver Cancer
- Bladder Cancer
- Others (Pancreatic, Ovarian etc.)
- Virtual Oncology Market, By Application
- Precision Medicine
- Patient Care Management
- Research & Development
- Clinical Trials
- Diagnosis & Treatment Decision Making
- Data Management
- Others (Billing Management, Regulatory Compliance etc.)
- Virtual Oncology Market, By End User
- Hospitals & Diagnostic Imaging Centers
- Academic Institutions & Research Centers
- Pharma & Biotech Companies
- Contract Research Organizations (CROs)
- Others (Reference Laboratories, Pharmacies etc.)
- Virtual Oncology Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles
- Flatiron Health
- McKesson Corporation
- Cerner Corporation
- Koninklijke Philips N.V.
- Siemens Healthcare Private Limited
- Crisp
- Varian Medical Systems, Inc.
- Elekta AB
- Accuray Incorporated
- C-TAC Health
- Oscar Health
- NXGN Management, LLC
- Epic Systems Corporation
- Optum, Inc
- CureMatch, Inc.
- Oncora Medical
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Virtual Oncology, By Component
- Market Virtual Oncology, By Cancer Type
- Market Virtual Oncology, By Application
- Market Virtual Oncology, By End User
- Market Virtual Oncology, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising prevalence of cancer globally
- Data privacy and security concerns
- Emerging markets exhibit significant growth potential
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Virtual Oncology Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Virtual Oncology Market , By Component, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Service
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Hardware
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Virtual Oncology Market, By Cancer Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Bladder Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others (Pancreatic, Ovarian etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Virtual Oncology Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Patient Care Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Research & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Clinical Trials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Diagnosis & Treatment Decision Making
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Data Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others (Billing Management, Regulatory Compliance etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Virtual Oncology Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Hospitals & Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Academic Institutions & Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Pharma & Biotech Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others (Reference Laboratories, Pharmacies etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Virtual Oncology Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
- North Africa
- South Africa
- Central Africa
10. Competitive Landscape
- Flatiron Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- McKesson Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cerner Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Siemens Healthcare Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Crisp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Varian Medical Systems, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Elekta AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Accuray Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- C-TAC Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oscar Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NXGN Management, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Epic Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Optum, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AI
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CureMatch, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Oncora Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
관련자료
